SBILIFE Share Price, Analysis & News

SBI Life Insurance Company Ltd (SBILIFE) — Updated on 2026-05-08

SBI Life Insurance Company Ltd operates within the insurance (life) sector, providing a range of life insurance products. The company's operations are structured across three distinct segments: Participating, Non-Participating, and Linked. Investors closely monitor the SBI Life Insurance Company Ltd share price to gauge its performance and market position. Understanding the SBI Life Insurance Company Ltd business model is crucial for analyzing its financial health and its ability to navigate the evolving trends within the Indian insurance industry. The company's focus on these core segments shapes its approach to earnings and its strategic outlook in a dynamic market.

Key Takeaway

Despite strong analyst buy ratings, SBILIFE shows neutral price action with its RSI at 50.05, trading significantly below its 52-week high.

Daily

2026-05-08
  • The stock is experiencing a neutral to slightly bearish short-term trend, with a minor -0.10% decline in the last day, despite a 2.82% gain over the past five days. This consolidation is supported by the price trading below its 50-day and 200-day moving averages, and momentum indicators like RSI at 50.05 showing a lack of strong conviction.
  • Fundamental performance presents a mixed picture, with a significant quarter-over-quarter revenue decrease of -91.18% and a year-over-year decline of -82.35%. However, net profit and EPS have shown sequential improvement, up 39.51% and 39.48% respectively, though they saw slight year-over-year decreases of -1.11% and -1.23%.
  • Analyst sentiment remains strongly positive, with 52.8% of analysts issuing a 'Strong Buy' rating and 47.2% a 'Buy' rating, a distribution that has been stable over the past month. There are no 'Hold', 'Sell', or 'Strong Sell' recommendations, indicating broad agreement among experts.
  • Ownership is concentrated, with promoters holding 55.33% of the stake. Institutional investors (FIIs and DIIs) collectively own 40.64%, with a slight decrease in FII holdings (-0.37%) and a slight increase in DII holdings (0.41%) quarter-over-quarter.
  • The stock is currently trading 11.14% below its 52-week high, indicating a significant drawdown from its peak performance. This suggests that while there are positive analyst ratings, the current price action reflects caution and a distance from recent highs.
Open daily analysis

Weekly

Latest weekly signal
  • The stock price rose 2.82% this week, marking a two-week streak of gains despite a 22.66% decline in trading volume.
  • Momentum indicators show a shift toward the upside, with the MACD (a tool used to identify trend direction) generating a bullish crossover.
  • CRISIL Ratings reaffirmed the company's 'CRISIL AAA/Stable' credit rating, citing its strong market position and support from the State Bank of India.
  • The company reported a 39.5% quarter-on-quarter increase in net profit for the period ending March 2026, despite significant year-on-year revenue contraction.
  • Technical analysis provided conflicting signals, as reports identified both an ascending triangle pattern and a death cross during the week.
Open weekly analysis

Quarterly

fy26-q4
  • Net Profit rose to ₹804.64 Cr (+39.5% QoQ), indicating strong sequential recovery driven by favorable non-recurring items. Profit Before Tax increased by 36.5% QoQ to ₹815.78 Cr, but declined 2.95% YoY, showing short-term profit strength within longer-term pressure. Gross Premium grew by 16.4% YoY to ₹27,938.86 Cr, indicating expanding market reach despite an 8.25% QoQ decrease. Expenses saw a substantial reduction, decreasing 92.4% QoQ to ₹3,463.95 Cr, reflecting effective cost management. Transfer from Policyholders Account surged 778% QoQ to ₹2,363.62 Cr, significantly boosting Shareholders Income and profitability.
Open quarterly analysis

Price & Technical Structure

  • Short-term returns have been subdued, with a -0.10% decline in the last day and a 2.82% gain over the past five days.
  • The trend regime is neutral, indicated by a negative trend alignment score of -1 and the price being slightly below the 50-day and 200-day moving averages.
  • Momentum is mixed, with a bullish MACD crossover but an RSI of 50.05, suggesting a lack of strong directional conviction.
  • Volatility remains within Bollinger Bands, with the price positioned near the middle band (49.1% of band width).
  • The stock is trading 11.14% below its 52-week high and has experienced a current drawdown of -11.14%.
The market behaviour indicates a neutral to slightly bearish short-term trend. While there are some bullish signals like a MACD crossover, the overall picture is one of consolidation. The price is trading below key EMAs and DMAs, and momentum indicators like RSI are not showing strong conviction. Volatility is moderate, and the stock is significantly off its highs, suggesting caution. Volume conviction is not particularly strong, further reinforcing the neutral stance.

Weekly Momentum

  • The stock price rose 2.82% this week, marking a two-week streak of gains despite a 22.66% decline in trading volume.
  • Momentum indicators show a shift toward the upside, with the MACD (a tool used to identify trend direction) generating a bullish crossover.
  • CRISIL Ratings reaffirmed the company's 'CRISIL AAA/Stable' credit rating, citing its strong market position and support from the State Bank of India.
  • The company reported a 39.5% quarter-on-quarter increase in net profit for the period ending March 2026, despite significant year-on-year revenue contraction.
  • Technical analysis provided conflicting signals, as reports identified both an ascending triangle pattern and a death cross during the week.
The stock experienced a period of price recovery this week, supported by a two-week positive streak and a bullish MACD crossover. While the company faces operational challenges reflected in a sharp year-on-year revenue decline, it maintained profitability through other income and received a stable credit rating from CRISIL. Market sentiment remains mixed, as technical indicators present conflicting signals regarding the stock's short-term direction.

Quarterly Analysis

Net Profit rose to ₹804.64 Cr (+39.5% QoQ), indicating strong sequential recovery driven by favorable non-recurring items.
Profit Before Tax increased by 36.5% QoQ to ₹815.78 Cr, but declined 2.95% YoY, showing short-term profit strength within longer-term pressure.
Gross Premium grew by 16.4% YoY to ₹27,938.86 Cr, indicating expanding market reach despite an 8.25% QoQ decrease.
Expenses saw a substantial reduction, decreasing 92.4% QoQ to ₹3,463.95 Cr, reflecting effective cost management.
Transfer from Policyholders Account surged 778% QoQ to ₹2,363.62 Cr, significantly boosting Shareholders Income and profitability.
Profitability was significantly boosted by a large sequential increase in funds transferred from policyholders, alongside a substantial reduction in expenses. While this drove strong quarter-over-quarter profit growth, the year-over-year profit decline and sequential dip in gross premium suggest underlying pressures despite effective cost management.
Profitability for the quarter showed a strong sequential recovery. Net Profit increased by 39.5% quarter-over-quarter to ₹804.64 Crores. This sequential profit growth was supported by a substantial increase in Transfer from Policyholders Account, which rose by 778% QoQ to ₹2,363.62 Crores. This large shift of funds significantly boosted Shareholders Income.

While profitability saw strong sequential gains, the year-over-year comparison presented a different picture. Profit Before Tax decreased by 2.95% YoY to ₹815.78 Crores, despite a 36.5% increase QoQ. This indicates short-term profit strength within a context of longer-term pressure.

The company experienced robust year-over-year growth in its top line. Gross Premium income grew by 16.4% YoY to ₹27,938.86 Crores. However, this was accompanied by a sequential decrease of 8.25% QoQ, suggesting a recent dip in premium collection momentum.

Expenses were significantly lower this quarter. Total Expenses decreased by 92.4% QoQ to ₹3,463.95 Crores. This substantial reduction in expenses, alongside premium growth, points to effective cost management and operational efficiency.